The store will not work correctly when cookies are disabled.
8-(4-hydroxyphenyl)-1,3-dimethyl-7,8-dihydro-1H-imidazo[1,2-f]purine-2,4(3H,6H)-dione
ID: ALA4781871
Cas Number: 913555-66-5
PubChem CID: 42589793
Max Phase: Preclinical
Molecular Formula: C15H15N5O3
Molecular Weight: 313.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c(=O)c2c(nc3n2CCN3c2ccc(O)cc2)n(C)c1=O
Standard InChI: InChI=1S/C15H15N5O3/c1-17-12-11(13(22)18(2)15(17)23)20-8-7-19(14(20)16-12)9-3-5-10(21)6-4-9/h3-6,21H,7-8H2,1-2H3
Standard InChI Key: JIQSWTJUHBHICU-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
16.7111 -14.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7111 -15.6422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4164 -16.0467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4164 -14.4123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1217 -14.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1262 -15.6387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9014 -15.8859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4164 -13.5951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0040 -16.0518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4169 -16.8639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0022 -14.4185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8964 -14.5716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3718 -15.2202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1356 -14.9685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1323 -14.1643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3664 -13.9191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7987 -15.4461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7124 -16.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3747 -16.7352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1209 -16.3998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2007 -15.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5375 -15.1084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7846 -16.8765 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 13 2 0
12 5 1 0
4 8 2 0
2 9 2 0
3 10 1 0
1 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
14 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 313.32 | Molecular Weight (Monoisotopic): 313.1175 | AlogP: 0.29 | #Rotatable Bonds: 1 |
Polar Surface Area: 85.29 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.23 | CX Basic pKa: ┄ | CX LogP: 1.33 | CX LogD: 1.33 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.70 | Np Likeness Score: -1.43 |
References
1. Schoeder CT,Mahardhika AB,Drabczyńska A,Kieć-Kononowicz K,Müller CE. (2020) Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18., 11 (10): [PMID:33062188] [10.1021/acsmedchemlett.0c00208] |